Sumatriptan

Overview

Sumatriptan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL128).

API suppliers (18)

Suppliers of Sumatriptan backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• APITORIA PHARMA PRIVATE LTDIndia2 active DMF
• JBC Pharmaceuticals Ltd.United Kingdom2 active DMF
• MSN PHARMACHEM PRIVATE LTD2 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Natco PharmaIndia1 active DMF
• Natco PharmaIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• Natco PharmaIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• DPT Laboratories, Ltd.United States1 active DMF
• MOEHS IBERICA SLSpain1 active DMF
• Hovione FarmaCiencia SAPortugal
• QUIMICA SINTETICA SASpain
• Cipla USA, Inc.USA
• APOTEX PHARMACHEM INC

Patent & exclusivity (US)

Per the FDA Orange Book (52 approved US products), the latest listed US patent on Sumatriptan expires 29 Jan 2036. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide

Canonical SMILES

CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C

InChIKey

KQKPFRSPSRPDEB-UHFFFAOYSA-N